With Cemiplimab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from With Cemiplimab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In With Cemiplimab Today - Breaking & Trending Today

When Does the PD-1 Inhibitor Come Before the Hedgehog Inhibitor for Neoadjuvant BCC/CSCC?

Published: April 11, 2024

Experts discuss when to use the PD-1 inhibitor cemiplimab vs the hedgehog inhibitor vismodegib as neoadjuvant treatment in non-melanoma skin cancers.

Source: onclive.com

Related Topics:

United StatesUniversity Of California San FranciscoVishala PatelRebeccai HartmanAnne Lynns ChangMichaelr MigdenSarah ArronJohnm StrasswimmerDermatology Associates Of The Palm BeachesDepartment Of DermatologyPeninsula Dermatology Medical Group In BurlingameHarvard Medical SchoolGw Cancer CenterRegeneron Pharmaceuticals IncUniversity Of Texas Md Anderson Cancer CenterEuropean UnionTreatment StrategiesSkin CancerCutaneous OncologyDermatologic SurgeryGeorge Washington University SchoolHealth SciencesWith CemiplimabHedgehog Inhibition With VismodegibMohs Surgeon